Mostra i principali dati dell'item

dc.contributor.authorPerez, MJ
dc.contributor.authorGonzalez-Sanchez, E
dc.contributor.authorGonzalez-Loyola, A
dc.contributor.authorGonzález de Buitrago Arriero, José Manuel 
dc.contributor.authorGarcía Marín, José Juan 
dc.date.accessioned2025-01-27T15:35:20Z
dc.date.available2025-01-27T15:35:20Z
dc.date.issued2011
dc.identifier.citationPerez, M. J., Gonzalez‐Sanchez, E., Gonzalez‐Loyola, A., Gonzalez‐Buitrago, J. M., & Marin, J. J. G. (2011). Mitochondrial genome depletion dysregulates bile acid‐and paracetamol‐induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. British journal of pharmacology, 162(8), 1686-1699.es_ES
dc.identifier.issn0007-1188
dc.identifier.urihttp://hdl.handle.net/10366/162980
dc.description.abstract[EN] BACKGROUND AND PURPOSE Mitochondria are involved in the toxicity of several compounds, retro-control of gene expression and apoptosis activation. The effect of mitochondrial genome (mtDNA) depletion on changes in ABC transporter protein expression in response to bile acids and paracetamol was investigated. EXPERIMENTAL APPROACH Hepa 1-6 mouse hepatoma cells with 70% decrease in 16S/18S rRNA ratio (Rho cells) were obtained by long-term treatment with ethidium bromide. KEY RESULTS Spontaneous apoptosis and reactive oxygen species (ROS) generation were decreased in Rho cells. Following glycochenodeoxycholic acid (GCDCA) or paracetamol, Rho cells generated less ROS and were more resistant to cell death. Apoptosis induced by GCDCA and Fas was also reduced. The basal expression of Mdr1 was significantly enhanced, but this was not further stimulated by GCDCA or paracetamol, as observed in wild-type (WT) cells. Basal expression of Mrp1 and Mrp4 was similar in WT and Rho cells, whereas they were up-regulated only in WT cells after GCDCA or paracetamol, along with the transcription factors Shp and Nrf2, but not Fxr or Pxr. Increased expression of Nrf2 was accompanied by its enhanced nuclear translocation. Glycoursodeoxycholic acid failed to cause any of the effects observed for GCDCA or paracetamol. CONCLUSIONS AND IMPLICATIONS The Nrf2-mediated pathway is partly independent of ROS production. Nuclear translocation of Nrf2 is insufficient to up-regulate Mdr1, Mrp1 and Mrp4, which requires the participation of other regulatory element(s) whose activationes_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherWiley. British Pharmacological Societyes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectABC proteins;es_ES
dc.subjectparacetamoles_ES
dc.subjectbile acides_ES
dc.subjectcholestasises_ES
dc.subjectdrug toxicityes_ES
dc.subjectliveres_ES
dc.subjectmitochondriaes_ES
dc.subjectmultidrug resistancees_ES
dc.subjectretrograde controles_ES
dc.subjectrho cellses_ES
dc.subject.meshDNA, Mitochondrial *
dc.subject.meshAcetaminophen *
dc.subject.meshCholestasis *
dc.titleMitochondrial genome depletion dysregulates bile acid‐ and paracetamol‐induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1111/j.1476-5381.2010.01174.xes_ES
dc.subject.unesco3209 Farmacologíaes_ES
dc.identifier.doi10.1111/j.1476-5381.2010.01174.x
dc.relation.projectIDCarlos III, FIS CP05/0135es_ES
dc.relation.projectIDCarlos III, FIS PI070517es_ES
dc.relation.projectIDCarlos III, FIS PI080151es_ES
dc.relation.projectIDJunta de Castilla y Leon GR75-2008es_ES
dc.relation.projectIDMinisterio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and the European Regional Development Fund (ERDF) BFU2006-12577es_ES
dc.relation.projectIDMinisterio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and the European Regional Development Fund (ERDF) SAF2009-08493es_ES
dc.relation.projectIDFundación Investigación Médica Mutua Madrileña Conv-VI, 2009es_ES
dc.relation.projectIDEster González-Sánchez is a recipient of a predoctoral fellowship from the Ministerio de Educación, Spain (Grant AP2008-03762).es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/closedAccesses_ES
dc.identifier.pmid21175587
dc.identifier.essn1476-5381
dc.journal.titleBritish Journal of Pharmacologyes_ES
dc.volume.number162es_ES
dc.issue.number8es_ES
dc.page.initial1686es_ES
dc.page.final1699es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decscolestasis *
dc.subject.decsADN mitocondrial *
dc.subject.decsacetaminofén *


Files in questo item

Thumbnail
Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional